AU785368B2 - Maize mip synthase promoter - Google Patents

Maize mip synthase promoter Download PDF

Info

Publication number
AU785368B2
AU785368B2 AU19371/01A AU1937101A AU785368B2 AU 785368 B2 AU785368 B2 AU 785368B2 AU 19371/01 A AU19371/01 A AU 19371/01A AU 1937101 A AU1937101 A AU 1937101A AU 785368 B2 AU785368 B2 AU 785368B2
Authority
AU
Australia
Prior art keywords
plant
sequence
seq
base pairs
mip synthase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19371/01A
Other versions
AU1937101A (en
Inventor
Katherine Armstrong
Otto Folkerts
Timothy D. Hey
Nicole L. Hopkins
Kelley A. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Dow AgroSciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow AgroSciences LLC filed Critical Dow AgroSciences LLC
Publication of AU1937101A publication Critical patent/AU1937101A/en
Application granted granted Critical
Publication of AU785368B2 publication Critical patent/AU785368B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823Reproductive tissue-specific promoters
    • C12N15/8234Seed-specific, e.g. embryo, endosperm
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Description

WO 01/40440 PCT/US00/32645 MAIZE MIP SYNTHASE PROMOTER Field of the Invention The invention provides DNA sequences and constructs that are useful in genetic engineering of plants. More particularly, the invention provides an isolated DNA sequence encoding maize myo-inositol-l-phosphate synthase (MIP synthase)and novel regulatory sequences derived from the MIP synthase gene, that can be used to drive expression of a variety of nucleic acid sequences in embryo tissue of transgenic plants.
Background of the Invention Plant genetic engineering projects require access to a variety of genetic elements that are used to regulate transgene expression. A primary example is the promoter, which regulates initiation of transcription.
A need exists for a variety of promoters for use in genetic engineering of plants. In particular, a need exists for promoters that drive expression specifically in embryo tissue.
Brief Description of the Sequences SEQ ID NO:1 is the DNA sequence for maize MIP synthase.
SEQ ID NO:2 is the amino acid sequence for maize MIP synthase.
SEQ ID NO:3 is the DNA sequence for the embryo specific maize MIP synthase promoter.
Summary Of The Invention The invention provides an isolated DNA molecule encoding maize MIP synthase.
WO01/40440 PCTIUS0/32645 In another of its aspects, the invention provides embryo specific maize MIP synthase promoters corresponding to or derived from SEQ ID NO:3.
In another of its aspects, the invention provides a DNA construct comprising, operatively linked in the 5' to 3' direction, a) a maize MIP synthase promoter; b) a DNA sequence of interest; and c) a 3'UTR.
In another of its aspects, the invention provides a plasmid comprising a maize MIP synthase promoter, preferably bp 7-2064 of SEQ ID NO 3.
In another of its aspects, the invention provides a transformed plant comprising at least one plant cell that contains a DNA construct of the invention. The plant may be a monocot or dicot. Preferred plants are maize, rice, cotton and tobacco.
In another of its aspects, the invention provides seed or grain that contains a DNA construct of the invention.
Detailed Description of the Invention The DNA sequence of interest used in constructs of the invention may be any gene that it is desired to express or down regulate in plants. Particularly useful genes are those that confer tolerance to herbicides, insects, or viruses, and genes that provide improved nutritional value or processing characteristics of the plant.
Examples of suitable agronomically useful genes include the insecticidal gene from Bacillus thuringiensis for conferring insect resistance and the 5'-enolpyruvyl-3'phosphoshikimate synthase (EPSPS) gene and any variant thereof for conferring tolerance to glyphosate WO 01/40440 PC/US00/32645 herbicides. As is readily understood by those skilled in the art, any agronomically important gene conferring a desired trait or producing an important protein can be used.
The 3' UTR, or 3' untranslated region, employed in constructs of the invention is one that confers efficient processing of the mRNA, maintains stability of the message and directs the addition of adenosine ribonucleotides to the 3' end of the transcribed mRNA sequence. The 3' UTR may be native with the promoter region, native with the structural gene, or may be derived from another source. A wide variety of termination regions are available that may be obtained from genes capable of expression in plant hosts, e.g., bacterial, opine, viral, and plant genes. Suitable 3' UTRs include but are, not limited to: the per5 3' UTR (W098/56921), the 3' UTR of the nopaline synthase (nos) gene, tmL or acp for example.
The present invention is generally applicable to the expression of structural genes in both monocotyledonous and dicotyledonous plants. This invention is particularly suitable for any member of the monocotyledonous (monocot plant family including, but not limited to, maize, rice, barley, oats, wheat, sorghum, rye, sugarcane, pineapple, yams, onion, banana, coconut, and dates. A preferred application of the invention is in production of transgenic maize plants.
The invention is particularly applicable to the family Graminaceae, in particular to maize, wheat, rice, oat, barley and sorghum. Dicotyledonous species include tobacco, tomato, sunflower, cotton, sugarbeet, potato, lettuce, melon, soybean and canola (rapeseed).
WO 01/40440 PCTUS00/32645 The present invention also includes DNA sequences having substantial sequence homology with the specifically disclosed regulatory sequences, such that they are able to have the disclosed effect on expression.
As used in the present application, the term "substantial sequence homology" is used to indicate that a nucleotide sequence (in the case of DNA or RNA) or an amino acid sequence (in the case of a protein or polypeptide) exhibits substantial, functional or structural /0 equivalence with another nucleozide or amino acid sequence. Any functional or structural differences between sequences having substantial sequence homology will be de minimis; that is they will not affect the ability of the sequence to function as indicated in the present application. Sequences that have substantial sequence homology with the sequences disclosed herein are usually variants of the disclosed sequence, such as mutations, but may also be synthetic sequences.
In most cases, sequences having 95% homology to the sequences specifically disclosed herein will function as equivalents, and in many cases considerably less homology, for example 75% or 80%, will be acceptable.
Locating the parts of these sequences that are not critical may be time consuming, but is routine and well within the skill in the art.
It is contemplated that sequences corresponding to the above noted sequences may contain one or more modifications in the sequences from the wild-type but will still render the respective elements comparable with respect to the teachings of this invention. For example, as noted above, fragments may be used. One may incorporate modifications into the isolated sequences includina the addition, deletion, or nonconservative WO 01/40440 PCT/US00/32645 substitution of a limited number of various nucleotides or the conservative substitution of many nucleotides.
Further, the construction of such DNA molecules can employ sources which have been shown to confer enhancement of expression of heterologous genes placed under their regulatory control. Exemplary techniques for modifying oligonucleotide sequences include using polynucleotide-mediated, site-directed mutagenesis. See Zoller et al. (1984), DNA, 3:479-488; Higuchi et al.
(1988), Nucl. Acids Res., 16:7351-7367, Ho et al. (1989), Gene, 77:51-59, Horton et al. (1989), Gene, 77:61; and PCR Technology: Principles and Applications for DNA Amplification, Erlich (1989)).
Conventional technologies for introducing biological material into host cells include electroporation (see Shigekawa and Dower (1988), Biotechniques, 6:742; Miller, et al. (1988), Proc. Natl. Acad. Sci. USA, 85:856-860; and Powell, et al (1988), Appl. Environ. Microbiol., 54:655-660); direct DNA uptake mechanisms (see Mandel and Higa (1972), J. Mol. Biol., 53:159-162; Dityatkin, et al.
(1972), Biochimica et Biophysica Acta, 281:319-323; Wigler, et al. (1979), Cell, 16:77; and Uchimiya, et al.
(1982), In: Proc. 5th Intl. Cong. Plant Tissue and Cell Culture, A. Fujiwara Jap. Assoc. for Plant Tissue Culture, Tokyo, pp. 507-508); fusion mechanisms (see Uchidaz, et al. (1980), In: Introduction of Macromolecules Into Viable Mammalian Cells, Baserga et al. (eds.) Wistar Symposium Series, 1:169-185); infectious agents (see Fraley, et al. (1986), CRC Crit.
Rev. Plant Sci., 4:1-46); and Anderson (1984), Science, 226:401-409); microinjection mechanisms (see Crossway, et al. (1986), Mol. Gen. Genet., 202:179-185); and high velocity projectile mechanisms (see EPO 0 405 696 to WO 01/40440 PCT/US00/32645 Miller, Schuchardt, Skokut and Gould, (The Dow Chemical Company) The appropriate procedure to transform a selected host cell may be chosen in accordance with the host cell used.
Based on the experience to date, there appears to be little difference in the expression of genes, once inserted into cells, attributable to the method of transformation itself. Once introduced into the plant tissue, the expression of the structural gene may be assayed in a transient expression system, or it may be determined after selection for stable integration within the plant genome.
Techniques are known for the in vitro culture of plant tissue, and, in a number of cases, for regeneration into whole plants. The appropriate procedure to produce mature transgenic plants may be chosen in accordance with the plant species used. Regeneration varies from species to species of plants. Efficient regeneration will depend upon the medium, on the genotype, and on the history of the culture. Once whole plants have been obtained, they can be sexually or clonally reproduced in such a manner that at least one copy of the sequence is present in the cells of the progeny. Seed from the regenerated plants can be collected for future use, and plants grown from this seed. Procedures for transferring the introduced gene from the originally transformed plant into commercially useful cultivars are known to those skilled in the art.
In one of its aspects, the invention is regarded as encompassing any deleted version of the MIP synthase promoter that provides a functional plant promoter. Such promoters are encompassed by the term "MIP synthase promoter". A sequence will be regarded as providing a WO 01/40440 PC/M264 "functional" promoter for purposes of this application if it gives transient GUS expression above background levels when tested as in Example 4. Those skilled in the art will understand that various deletions from the 2058 bp sequence (bp 7-2064 of SEQ ID NO:3) can be made without destroying functionality of the sequence as a promoter.
Deletion experiments are within the skill in the art.
Preferably, a promoter of the invention will comprise 200 contiguous base pairs that are identical to 200 contiguous base pairs of the sequence defined by bp 7- 2064 of SEQ ID NO:3. More preferable are promoters that comprise 500 contiguous base pairs that are identical to 500 contiguous base pairs of the sequence defined by bp 7-2064 of SEQ ID NO:3.
Throughout the description and claims of this specification, use of the word "comprise" and variations of the word, such as "comprising" and "comprises", is not intended to exclude other additives, components, integers or steps.
The discussion of documents, acts, materials, devices, articles and the like is included in this specification solely for the purpose of providing a context for the present invention. It is not suggested or represented that any or all of these matters formed part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed in Australia before the priority date of each claim of this application.
In the following examples, standard methods of DNA purification, restriction enzyme digestion, agarose gel analysis, DNA fragment isolation, ligation and transformation were used, as described in Sambrook, Fritsch, E.F, and Maniatis, T. (1989); Molecular Cloning a Laboratory Manual, second edition. (Cold Spring Harbor: Cold Spring Harbor Laboratory Press), Ausubel, Brent, Kingston, Moore, Smith, Seidman, and Struhl, eds. (1987); and Current Protocols in Molecular Biology. (New York: John Wiley and Sons).
WO 01/40440 PCT/US00/32645 Example 1 Cloning of a maize cDNA encoding MIP Synthase A. Isolation of a Maize MIP Synthase Probe Using Degenerate Primers A probe was isolated by PCR amplification of maize embryo cDNA using degenerate primers designed from the yeast MIP synthase amino acid sequence. At the time only the yeast MIP synthase sequence was known (Johnson, M. and Henry, S. (1989). Biosynthesis of Inositol in Yeast: Primary Structure of Myo-Inositol-l-Phosphate Synthase (EC 5.5.1.4) and Functional Analysis of its Structural Gene, the INO1 Locus. J. Biol. Chem. 264: 1274-1283.), it was not possible to identify "conserved" regions of the MIP synthase protein sequence. As an alternative, those amino acids that are encoded by only one or two codons were identified in the yeast protein sequence. Stretches of five or more of these low redundancy amino acids were selected as regions for primer design.
A clone (MP18) that could be translated into protein that had identity with yeast MIP synthase was identified.
The insert of MIP18 was gel purified, labeled with 32 p and used to probe a lambda maize embryo cDNA library.
B. Isolation of a Maize MIP Positive cDNAs Protocols for phage plating, plaque purification and in vivo excisions were as recommended by the manufacturer (Stratagene, LaJolla CA). Some changes were introduced and are noted below.
E. coli XL-1 blue were grown in NZY media containing 0.2% maltose to an optical density of 1.0 at 520 nm. The 8 WO 01/40440 PCT/US00/32645 cells were collected by cenzrifugation at low speed and resuspended to the same density in 10 mM MgSO4. Cells were stored for several days at 4 0 C with little loss in plaque forming efficiency. Phage were preabsorbed to 200 iL of cells for 15 minutes at room temperature in Falcon 2059 tubes followed by 15 minutes at 37 0 C. The cells were plated in 3 mL NZY agarose at 48 0 C on to NZY plates.
Plates were incubated at 37 0 C overnight.
Plates were chilled, 0.22 micron nylon filters were gently applied to the plate and allowed to absorb phage for 2 minutes. The filters were transferred to blotting paper saturated with 0.5 M NaOH, 1.5 M NaCl for minutes. The filters were allowed to dry for 5 minutes then transferred to blotting paper saturated with a neutralization solution of 0.5M Tris pH 7.6, 1.5M NaCl for 15 minutes. The filters were then cross-linked using a Stratagene UV cross-linker on the "auto" setting. The filters were washed with two changes of 2X SSC, 0.1% SDS.
Prehybridization was a minimum of 6 hours in 6X SSC, Denhardt's solution, 0.1% SDS, 200 mg/mL DNA at 42 0
C.
DNA fragments were isolated using the Qiaex purification methods of Qiagen Inc., (Chatsworth, CA). The Boehringer Mannheim Random Primed DNA Labeling Kit (Indianapolis, IN) was used following manufacturer's instructions.
Unincorporated nucleotides were removed by gel filtration through a Stratagene PUSH column following manufacturer's recommendations.
Hybridization solution for low stringency hybridization was 6X SSC, 10X Denhardt's solution, 0.1% SDS, 200 mg/mL WO 01/40440 PCT/US00/32645 DNA, 42 0 C, 6 hours. Low stringency washes were 40 0 C, 6X SSC, 1% SDS, 4 changes in a total of 2 liters.
Hybridization solution for high stringency was as above except adjusted to 50% deionized formamide. Wash conditions were 0.1% SSC, 0.1% SDS, 600C, 4 changes in a total of 2 liters.
The primary screen yielded many positive plaques that appeared on duplicate filters. The frequency of positive plaques approached 1% indicating that the gene was highly expressed in embryo. Several plaques were picked and screened a second and third time. Eight single plaques were picked from pure stocks and the plasmics rescued for cDNA insert analysis.
The eight MIP synthase positive clones were digested with restriction endonucleases Eco RI and Xho I to release the inserts from the vector. Based on the yeast sequence, a cDNA insert of approximately 2 kb was expected, this includes 500 amino acids of coding capacity and several hundred base pairs of nontranslated sequence. Two clones contained inserts that comigrated with the 2 kb marker.
The other six clones contained inserts significantly smaller in size and were not characterized further. One clone with a cDNA insert of approximately 2 kb was chosen for DNA sequence analysis, it was called clone pMIP-7.
C. DNA Sequence Analysis of Maize MIP synthase cDNA The DNA sequence and the deduced amino acid sequence for the maize MIP synthase is shown in SEQ ID NO:1. The cDNA is 1959 nucleotides in length. The 5' most ATG is located at position 137 giving a putative 5' noncoding WO 01/40440 PCTIUS00/32645 region of 136 nucleotides. A large open reading frame exzends from the ATG at position 137 to a stop codon at position 1667. The reading frame encodes a polypeptide of 510 amino acids. A stop codon is located at position 1667 followed by 248 nucleotides of 3' nontranslated region. A short poly tract is located at position 1918.
Example 2 Analysis of Tissue Specific and Developmental Patterns in Seed Mycogen proprietary maize genotypes CS608, HO1, CQ906, OQ414, and Hill, and a commonly available inbred B73, were grown under standard greenhouse conditions. For analysis of tissue specific gene expression of the MIP synthase promoter, tissues were harvested at the developmental times of interest and frozen at -70 0 C until RNA extraction. For determination of the temporal expression pattern of MIP in seed embryos, kernels were dissected from ears of CQ806 and HO1 at different days after pollination (DAP). Following harvest, kernels were immediately dissected, embryos were collected and frozen in 50 ml conical tubes on dry ice. RNA was extracted and prepared for northern analysis using standard techniques.
A MIP synthase hybridization probe was prepared from plasmid pMIP7 (for a description see Example 1) by digestion with EcoRl and Xhol, followed by gel purification of the approximately 1950 bp insert.
Twenty-five nanogram of gel-purified fragment was labeled with 50 uCi [a-32P]-dCTP (NEN Research Products) using READY-TO-GO labeling beads (Pharmacia) according to the manufacturer and purified over NUCTRAP push columns (Stratagene). The labeled probe was denatured by boiling for 5 min, chilled on ice for 5 min, and added directly to the prehybridized blots. Hybridization was done in WO 01/40440 PCTIUS00/32645 SEAL-A-MEAL bags (DAZEY Corp., Industrial Airport, KA), at 42 0 C for 16 h. Blots were washed six times for 30 min in large excess (500 mL) of pre-warmed washing solution mM sodium phosphate pH6.5, 50 mM NaC1, 1 mM EDTA, and 0.1% SDS] at 60 0 C. Hybridization results indicated that MIP synthase was expressed in embryo tissues from each of the maize genotypes tested. Maximum expression in the embryos was observed 18-27 DAP. No significant expression was observed in leaves or roots. These data suggested that expression of MIP synthase was preferentially regulated in embryo tissues.
Example 3 Cloning Of The 5' Untranslated Regions from the Maize MIP Synthase Gene The maize MIP synthase 5' flanking sequences were isolated from maize genomic DNA, var. 00414 (proprietary line of Agrigenetics Inc., d/b/a Mycogen Seeds). DNA sequencing was accomplished using the ABI Prism DNA Sequencing Kit with AmpliTaq® Polymerase FS as described by the manufacturer (Perkin Elmer/Applied Biosystems Division, Foster City, CA). Sequencing reactions were run on an Applied Biosystem 373A DNA sequencer (Perkin Elmer/Applied Biosystems Division). The DNA sequence for the MIP synthase promoter is given in SEQ ID NO:3.
Description of Vectors Four expression vectors were constructed which incorporated the MIP synthase promoter upstream from the P-glucuronidase (GUS) gene on a pUC19 backbone.
pMipGP339-1 and pMipGN345-1 were designed to test GUS expression in transient assays. The difference between these two vectors was that different 3' untranslated sequences were used as transcription terminators.
12 WO 01/40440 PCT/US00/32645 pMipGP339-1 used the per5 3'UTR; pMipGN345-1 used the nos 3'UTR.
pMipGP341 and pMipGN350-1 are derivatives of pMipGP339-1 and pMipGN345-1 that add a selectable marker gene (phosphinotricin acetyl transferase (BAR) gene of Streptomyces hygroscopicus (White et al., (1989) Nucleic Acids Res. 18:1062)) driven by a double enhanced promoter. pMipGP341 and pMipGN350-l were used to test the MIP synthase promoter/GUS fusions in stably transformed maize embryos.
Plasmid UGP232-4 was used as a positive control in the transient expression studies. UGP232-4 is similar to pMipGP339, except that the GUS gene is driven by the ubiquitin 1 (ubi) promoter and intron I from maize in place of the MIP synthase promoter.
Plasmid pDAB305 was used as a control in the transient expression studies to standardize GUS expression across multiple experiments. pDAB305 is similar to pMipGN345-1, but uses the double enhanced 35S promoter used in pMipGN350-1 to drive expression of the GUS gene.
Production of the GUS protein from genes controlled by different promoter versions was often compared relative to an internal control gene that produced firefly luciferase (De Wet et al. (1987). Mol. Cell. Biol. 7(2), 725-37). A plasmid (pT3/T7-1 LUC) containing the luciferase (LUC) coding region was purchased from CLONTECH (Palo Alto, CA), and the coding region was modified at its 5' and 3' ends by standard methods to permit the isolation of the intact luciferase coding region on a 1702 bp fragment following digestion by NcoI and BglII. This fragment was used to replace the GUS gene of plasmid pDAB305, so that the luciferase coding WO 01/40440 PCT/US00/32645 region was expressed from the enhanced 35S promoter, resulting in plasmid pDeLux.
Example 4 Transient Testing Of Mip Synthase-Gus Constructs A. Transient histochemical GUS expression in embryos.
Three single gene plasmids were used for testing transient expression of GUS driven by the MIP synthase promoter in maize embryos. pUGP232-4 (encoding the maize ubiquitin promoter fused to GUS with the per5 3' UTR) served as a positive control. pMipGP339-1 and pMipGN345- 1 contained a MIP synthase promoter-GUS fusion with the and Nos 3' ends, respectively. Immature zygotic embryos from the "Hi-II" genotype (Armstrong et al.
(1991) Maize Genet. Coop. News Lett. 65:92-93) were harvested at 12, 18, and 20 days after pollination (DAP).
The embryos were cultured one to two days on callus initiation medium consisting of N6 salts and vitamins (Chu et al, (1978) The N6 medium and its application to anther culture of cereal crops. Proc.
Symp. Plant Tissue Culture, Peking Press, 43-56), mg/L 2,4-dichlorophenoxyacetic acid 25mM Lproline, 100 mg/L casein hydrolysate, 10 mg/L AgNO 3 g/L GELRITE (Schweizerhall, South Plainfield, NJ), and g/L sucrose, with a pH of 5.8 prior to autoclaving.
Before transformation, the embryos were transferred to medium (15Ag10 with 0.2 M sorbitol and 0.2 M mannitol) for four hours of osmotic pretreatment. For helium blasting, 12 embryos were arranged in a target area of approximately 1 cm 2 on blasting medium and covered with a 230 gm mesh stainless steel screen. Blasting medium differed from 15AglO+SM medium in that it lacked silver nitrate, contained only 6 mM L-proline and was WO 01/40440 PCT/US00/32645 solidified with 20 g/L TC agar (PhytoTechnology Laboratories, LLC, Shawnee Mission, KS).
DNA was prepared for blasting using equal molar amounts of the GUS plasmids. A total of 70 pg of DNA, test DNA plus Bluescript T DNA (Stratagene, La Jolla, CA) when necessary, was diluted in sterile water to a volume of 150 pL. The DNA and water were added to 30 mg of surfacesterilized 1.0 um spherical gold particles (Bio-Rad Laboratories, Hercules, CA). The mixture was vortexed briefly (approximately 15 seconds) before adding 37 uL of M calcium chloride and 15 pL of 0.1 M spermidine (free base). After vortexing for 30 seconds, the DNA and gold were allowed to precipitate from solution. The supernatant was removed and 1 mL of ethanol was added.
The DNA/gold mixture was diluted 1:4 before use for transformation.
Helium blasting accelerated suspended DNA-coated gold particles toward and into the prepared tissue targets.
The device used was an earlier prototype of that described in US Patent No. 5,141,131 which is incorporated herein by reference. Tissues were placed under a partial vacuum of 25 inches of Hg in the device chamber. DNA-coated gold particles were accelerated at each embryo target once using a helium pressure of 1500 psi, with each blast delivering 20 L of the DNA/gold suspension. Following blasting, the embryos were transferred back to 15AglO+SM medium and incubated in the dark at 27 0 C for 18-24 hours prior to GUS histochemical assay.
Embryos were subjected to histochemical GUS analysis (Jefferson (1987) Plant Mol. Biol. Rep. 5:387-405) by placing in 24-well microtiter plates containing 250-500 pL of assay buffer (0.1 M sodium phosphate, pH 8.0, WO 01/40440 PCT/US00/32645 potassium ferricyanide, 0.5 mM potassium ferrocyanide, mM disodium EDTA, 0.95 mM 5-bromo-4-chloro-3-indolylbeta-D-glucuronide, and 0.6% TRITON X-100] per well. A partial vacuum was drawn for 2-15 minutes prior to being incubated in the dark for 24-48 hours at 370 C.
Table 3 summarizes results of three experiments testing transient GUS expression of the MIP-synthase promoter in comparison to a maize ubiquitin control. Three to five targets (12 embryos/target) were blasted per construct in each experiment. Though not as intense as the control, the MIP synthase construct with the per5 3'UTR resulted in GUS expression in embryos harvested at 12, 18, and DAP. The MIP synthase plasmid with the Nos 3'end also demonstrated GUS activity in 20 DAP embryos. In conclusion, moderate levels of transient expression were observed with the MIP synthase promoter in immature zygotic embryos of maize.
Table 3.
Transient GUS Expression of MIP Synthase-GUS Constructs in Maize Embryos Days after Pollination Plasmid pUGP232-4 pMipGP339-1 pMipGN345-1 12 nt 18 nt nt=not tested B.Transient quantitative GUS expression in maize regenerable callus.
WO 01/40440 PCT/US00/32645 Plasmids pMipGP339-1 and pMipGN345-1 were tested in regenerable maize callus for an indication of the level to which the MIP synthase promoter drives constitutive expression. A modified 35S promoter/GUS construct (pDAB305), which is highly expressed in maize, was used as a control. Expression of GUS driven by either pMipGP339-1 or pMipGN345-1 was determined as a percent of GUS driven by pDAB305.
pMipGP339-1 and pMipGN345-1 each resulted in expression 3% of pDAB305 which was statistically different from the control. In conjunction with the embryo data above, the insignificant constitutive expression strongly indicates MIP synthase as an embryo specific promoter.
Example Production of Stably Transformed Maize Callus Type II callus cultures were initiated from immature zygotic embryos of the genotype "Hi-II." (Armstrong et al, (1991) Maize Genet. Coop. Newslett., 65: 92-93).
Embryos were isolated from greenhouse-grown ears from crosses between Hi-II parent A and Hi-II parent B or F 2 embryos derived from a self- or sib-pollination of a Hi- II plant. Immature embryos (1.5 to 3.5 mm) were cultured on 15AglO callus initiation medium as described herein.
After four to six weeks callus was subcultured onto callus maintenance medium (initiation medium in which AgNO 3 was omitted and L-proline was reduced to 6 mM).
Selection for Type II callus took place for ca. 12-16 weeks.
Plasmids pMipGN350-1 and pMipGP341 were independently transformed into embryogenic callus tissue. In preparation for helium blasting, 140 pg of plasmid DNA was precipitated onto 60 mg of alcohol-rinsed, spherical WO 01/40440 PCTIUS00/32645 gold particles (1.5 3.0 im diameter, Aldrich Chemical Co., Inc., Milwaukee, WI) by adding 74 pL of 2.5M CaC12 and 30 pL of 0.1M spermidine (free base) to 300 pL of plasmid DNA and H20. The solution was immediately vortexed and the DNA-coated gold particles were allowed to settle. The resulting clear supernatant was removed and the gold particles were resuspended in 1 ml of absolute ethanol. This suspension was diluted with absolute ethanol to obtain 15 mg DNA-coated gold/mL.
Approximately 600 mg of embryogenic callus tissue was spread over the surface of Type II osmotic medium as described herein. Following a 4 hour pre-treatment, tissue was transferred to culture dishes containing blasting medium as described herein. Targets were individually blasted with DNA/gold mixture using the helium blast device described herein. Tissues were covered with a stainless steel screen (104 pm openings) and placed under a partial vacuum of 25 inches of Hg in the device chamber. The DNA-coated gold particles were further diluted 1:1 with absolute ethanol prior to blasting and were accelerated at the callus targets four times using a helium pressure of 1500 psi, with each blast delivering 20 pL of the DNA/gold suspension. The targets were rotated 180° after each blast. The tissue was also mixed halfway through the procedure to expose unblasted callus. Immediately post-blasting, the tissue was transferred back to Type II osmotic medium for a 16- 24 h recovery period. Afterwards, the tissue was divided into small pieces and transferred to selection medium (maintenance medium lacking casein hydrclysate and Lproline but containing 30 mg/L BASTA® (AgrEvo, Berlin, Germany)). Every four weeks for three months, tissue pieces were non-selectively transferred to fresh WO 01/40440 PCT/US00/32645 selection medium. After 9 weeks and up to 21 weeks in selection, callus sectors found proliferating against a background of growth-inhibited tissue were removed and isolated. The resulting BASTA®-resistant tissue was subcultured biweekly onto fresh selection medium.
Example 6 Development of Mature Somatic Embryos and Regeneration of Transgenic Plants From these stably transformed cultures, somatic embryos were induced to develop as seed embryos by growing embryogenic callus on Murashige and Skoog basal medium, hereinafter MS medium (Murashige and Skoog, Physiol.
Plant. (1962) 15: 473-497) containing 60 g/L sucrose.
The callus was grown for seven days, and then somatic embryos were individually transferred to MS medium containing 60 g/L sucrose and 10M abscisic acid, hereinafter ABA, for an additional 7 days. After 14 days of maturation, somatic embryos from different transgenic lines were assayed for histochemical expression of the GUS gene by placing in approximately 400 pL of GUS solution as described herein except without drawing a vacuum. GUS-expressing lines and non-GUS-expressing lines were identified and transferred to regeneration media. Regeneration was initiated by transferring embryogenic callus tissue to cytokinin-based induction medium, MS medium containing 30 g/L sucrose, 100 mg/L myo-inositol, 30 g/L mannitol, 5 mg/L 6benzylaminopurine, hereinafter BAP, 0.025 mg/L 2,4-D, mg/L BASTA®, and 2.5 g/L GELRITE at pH 5.7. The cultures were placed in low light (125 ft-candles) for one week followed by one week in high light (325 ft-candles).
Following a two-week induction period, tissue was non- WO 01/40440 PCT/US00/32645 selectively transferred to hormone-free regeneration medium, which was identical to the induction medium except that it lacked 2,4-D and BAP, and was kept in high light. Small (3-5 cm) plantlets were removed and placed in 150x25 mm culture tubes containing Schenk and Hildebrandt salts and vitamins, hereinafter SH medium (Schenk and Hildebrandt, (1972) Can. J. Bot. 50:199-204), g/L sucrose, 100 mg/L myo-inositol, and 2.5 g/L GELRITE, pH At least one individual plantlet from each regenerable line was sacrificed for histochemical GUS assay. Intact plantlets (3-10 cm) were placed in mL conical centrifuge tubes and submersed in approximately 5-10 mL GUS assay buffer and incubated as described herein. Non-assayed plantlets were transferred to 12 cm round pots containing approximately 0.25 kg of METRO-MIX 360 (The Scotts Co. Marysville, OH) in the greenhouse as soon as they exhibited growth and developed a sufficient root system. They were grown with a 16 h photoperiod supplemented by a combination of high pressure sodium and metal halide lamps, and were watered as needed with a combination of three independent Peters Excel fertilizer formulations (Grace-Sierra Horticultural Products Company, Milpitas, CA). At the 6-8 leaf stage, plants were transplanted to five gallon pots containing approximately 4 kg METRO-MIX 360, and grown to maturity.
Primary regenerants were outcrossed with the elite inbred, 00Q414. RI seed was collected approximately 6 weeks post-pollination.
A total of 312 Type II callus targets were blasted with pMipGN350-1 and pMipGP341. Thirty-six Basta®-resistant callus isolates were recovered from selection, however, only 29 were induced to form mature somatic embryos as WO 01/40440 PCT/US00/32645 described herein. Twenty-four of these events produced some level of blue staining following histochemical GUS assay, as described herein, ranging from very faint blue to a deep indigo blue. Thirteen of these expressers plus one maize ubiquitin/GUS/Nos positive control and one (non-GUS) transgenic negative control were regenerated.
Approximately 16 Rc plants were regenerated from each of these lines. Ten of the 13 MIP regenerants produced RI seed.
Example 7 Gus Analysis Of Transgenic Plants A. GUS analysis of embryos.
Embryos from pMipGP341-06.06, pMipGN350-05.01, pMipGN350- 14.01, 1817-02.11 (transgenic negative control), Whisker- 12.12 and Whisker-12.14 (maize Ubiquitin-GUS positive controls) were harvested 10 through 30 days after pollination (DAP) at 5 day intervals. Up to 10 kernels were collected per ear at each harvest depending on seed set of the Ro plants. According to the method of Jefferson (1987) Plant Mol. Biol. Rep. 5:387-405 as described herein, embryos were histochemically examined for GUS expression.
No GUS expression was observed in embryos of the trangenic negative control (1817-02.11). Unexpectedly, GUS was not detected in embryos of the Ubiquitin positive controls (Whisker-12.12 and Whisker-12.14). The growth of these plants was stunted and seed set was poor.
However, each of the three MIP synthase events demonstrated GUS expression in the RI embryos. In pMipGP341-06.06, expression was observed as early as DAP. For the p350 events, GUS was detected first at DAP. Expression in all lines continued through maturity WO 01/40440 PCT/US00/32645 at 30 DAP. Segregation generally followed Mendelian inheritance patterns.
B. GUS analysis of roots and leaves.
Two plants per transgenic event, as well as two nontransformed controls (OQ414), transformed negative controls (1817-02 plants), and positive controls expressing maize Ubiquitin-driven GUS (Whisker-12 events) were sacrificed at different developmental stages. One plant per event at the V6 (6 leaf) and VT (emerging tassel) stages was harvested and the leaves and roots were separately pooled for analysis. Additionally, the sixth leaf of several plants per event was collected at the V6 stage and individually evaluated for GUS expression.
No GUS activity was detected in the leaves or roots of the nontransformed (OQ414) or transformed negative (1817- 02) controls. Variable, yet significant, GUS expression was observed in the positive control (Whisker-12 event, seven plants), ranging from 0.45 to 2.34 ng GUS equivalent/ig protein in the leaves and 0.28 to 0.47 in the roots. The MIP synthase-GUS transgenic events demonstrated no significant GUS activity in leaves or roots, leading to the conclusion that the MIP synthase promoter is embryo specific.
EDITORIAL NOTE APPLICATION NUMBER 19371/01 The following Sequence Listing pages 1 to 6 are part of the description. The claims pages follow on pages "23" to "24a".
WO 01/40440 WO 0140440PCTIUSOOI32645 SEQUENCE LISTING <110> Armstrong, Katherine Hey, Timothy D Eolkerts, Otto Smith, Kelley A Hopkins, Nicole L <120> MAIZE MIP SYNTHASE PROMOTER <130> 50597 <140> <141> <150> US 60/168,612 <151> 1999-12-02 <160> 3 <170> PatentIn Ver. <210> 1 <211> 1959 <212> DNA <213> Zea mays <220> <221> CDS <222> (137) (1699) <400> 1 gaattcggca caagcaaagg agcgcggcgg cccctccttc cttcctccca ctzctctcgc gcggcgctcg cttacctcgc ctcgcattcc gttcgagcag gggagcggca gtgaaaaggg 120 agggaattaa gqcaag atg ttc atc gag agc ztc cgc gtc gag agc ccc cac 172 Met Phe Ile Glu Sex Phe Arg Val Glu Ser Pro His 1 5 gtg cgg tac ggc ccg acg gag etc gag tcg gag tac cgg tac gac acg 220 Val Arg Tyr Gly Pro Thr Gu Ile Glu Sex Glu Tyr Arg Tyr Asp Thr 20 acg gag ctg gtg cac gag gcc aag gac ggc gcc tcc cgc tgg gtc gtc 268 Thr Glu Leu Val His Glu Ala Lys Asp Gly Ala Ser Arg Trp Val Val 35 cgc ccc aag tcc gtc aaa tac aac ttc cgg acc agc acc gcg gtc ccc 316 Arg Pro Lys Ser Val Lys Tyr Asn Phe Axg Thr Ser Thr Ala Val Pro 50 55 aag ctc ggg gtc atg ctt gtg ggg tgg gga ggc aac aac ggg tcc acg 364 Lys Leu Gly Val Met Leu Val Gly Txp Gly Gly Asn Asn Gly Ser Thx 70 ctg acg gct cgg gtc att gcc aac agg gag ggg atc tca. tgg gcg acc 412 1 WO 01140440 PCTIUJSOOI32645 Giu Gy Ile S3er Trp Ala Thr Leu Thr aag gac Lys Asp tcc ac Ser Thr 110 ttc aag Phe Lys 125 ggc tgg Gly Trp aag gtg Lys Vai too atg Ser Met aac cag Asn Gin 190 cag gtg Gin Vai 205 aaa gtg Lys Val ago aat Ser Asn tot gtq Ser Val att gc Ile Ala 270 aac act Asn Thr 285 otg atc Leu Ilie Ala aag Lys atc Ile ago Ser gao Asp ctg Leu qt g Vali 175 ggo Gly gag Giia gac Asp qt a Val1 gao Asp 255 t gt Cys ttt Phe ggt Gly Gly gtg Vai aga Arg oto Len atc le gao Asp 160 cca Pro tot Ser cag G In a ag Lys tgt Cys 240 aag Lys gt C Va I gtg Val ggt Gly Val :le Ala Asn cag caa gc Gin Gin Ala gta Val1 ota Leu ago Ser 145 at t Ile o t Leu ogt Arg ato Ile gt a Val 225 got Al a aao Asn aog Thr oct Pro gao Asp ~305 ago Se r 115 at g Met atg Met ot g Leu ggt Gi y aao Asn 195 aaa Lys gt g Val otc Leu gog Al a ggg Gly 275 otg Leu tto Phe aac As n 100 tao Tyr gtq Val1 aao Asn oa g Gin gt 0 Val1 180 aat Asn cat Asp otg Leu aao Asn gag Gin 260 gt g ValI att 11ie aag Lys Arg 85 tao Tyr aao Asn aac Asn otg Len aag Lys 165 tatz Tyr gt o Val1 at o Ile tgg Trp gao Asp 245 ato Ile oog Pro ga t Asp agz- Ser t.ao ggo Tyr G~y ggg gag Gliy Gin oca gao Pro Asp 135 gca gat Ala Asp 130 cag oto C-in Leu cat cog Asp Pro ato aag Ile Lys agg gag Arg Gin 215 act goa Thr Ala 230 aoa. ata Thr Met.
tog oca Ser Pro tto ato Phe Ile ott got Len Ala 295 ggg oag Gly Gin 310 tco oto Ser Leu 105 gag a'ta Giu Ile 120 gao Ott Asp Len goo atg Ala Met agg 000 Arg Pro gao tto Asp Phe 185 ggo aoo Gly Thr 200 ttt aag Phe Lys aao act Asn Thr gag aat Gin Asn tca aca Ser Thr 265 aat ggg Asn Gly 280 ato aag Ile Lys aoo aag Thr Lys aco cag Thr Gin tat gog Tyr Ala gtg tt Val Phe aco agg Thr Arg 155 tao atg Tyr Met 170 a o goo Ile Ala aag aaa Lys Lys gag aag Giu Lys gaa agg Gin Arg 235 otg otg Leu Leu 250 ota tat Len Tyr ago co Ser Pro sac aao Asn Asn atg aaa Met Lys 315 got Aia cog Pro gga Gly 140 g 00 Al a gag Giu got: Ala gaa Gin aao As a 220 tac Tyr go a Al a gc Al a oag Gin t go Gys 300 t ug Ser 460 508 556 604 652 700 748 796 844 092 940 988 1036 1084 1132 gtc ctg gtt gat Val Leu Val Asp gtootggttgatttt ott gtt ggt got gga ata aag 000 aco tog att VaiLeuValAspPhe Leu Val Gly Ala Gly Ile Lys Pro Thr Ser Ile WO 01/40440 WO 0140440PCT/USOO/32645 330 Ctg tct gCC Leu Ser Ala gtg 9t9 gat Val Val Asp gag cat ccc Glu His Pro 380 gac agt aag Asp Ser Lys 395 ggc aaq agc Giy Lys Ser 410 gcc gca ccg Ala Ala Pro acg atc cag Arg Ile Gin CCg gtg gcc Pro Val Ala 460 ccc ggc aca Pro Gly Thr 475 gag aac atc Glu Asn le 490 atc ctg gag Ile Leu Glu gaggaggctg 1180 1228 1276 1324 1372 1420 1468 1516 1564 1612 1660 1709 1769 1829 1889 1949 1959 Tyr Lys cacgaagggg actagagagg cgagattagc tgtggaattg ttttgcgttc ttttcctggr catcgctgtg gcgcttttgt aacactatca gggctctgct attagcgctt gaaccctgta taatgtgatc gagggtgcta gttcccctaa aaaaaaaaaa gcccggtaCC tgttgc7tc tcgt-gttttc attttatttg ttggacccqt atggcattgg catcgtatga aaaaaaaaac tcgagggggg WO 01 /40440 <210> 2 <211> 510 <212> PRT <213> Zea mays <400> 2 Met Phe Ile Giu 1 Pro Thr Giu Ile His Glu Ala Lys 33 Val Lys Tyr Asn Met Leu Val Gly Val Ile Ala Asn Gin Gin Ala Asn 100 Val Gly Ser Tyr 115 Leu Pro Met Val 130 Ser Ser Met Asn 145 Ile Asp Leu Gin Leu Pro Gly Val 180 Arg Ala Asn Asn 195 Ile Ile Lys Asp 210 Val Vai Val Leu 225 Ala Gly Leu Asr.
Asn Glu Ala Glu 260 Thr Glu Gly Val 275 PCTUSOO/32645 Ser Glu Asp Phe T rp Arg Tyr As n As n Leu Lys 165 Tyr Vai Ile T rp Asp 245 Ile Pro Val1 Tyr Ser 40 Ser Asn Ile Ser Giu 120 Asp Al a Arg Asp Giy 200 Phe As n.
Giu Ser Asn ValI Thr Arg Lys Le u Lys Ser Phe 125 Gly Lys Ser As r.
Gi1n 2 Lys Ser Ser Ile As n 285 Pro Gly Leu Ile Asp Leu Ala Ile Lys Asn Asn Cys Leu Ile Gly Gly WO 01/40440 PCT/USOOI32645 290 Asp Phe Lys Ser Leu Val Gly Ala Thr Lys Met Val Leu Val Ile Lys Pro His Leu Gly Arg Ser Lys 355 Ser Asn Ala Asp Giy Met Thr Ser 11c 330 Leu Ser Ala Val Val Asp Val Scr Tyr Asn 335 Pro Ile Ser Lys C-in Thr Phe 350 Met Val Ser His Val Val Ile Leu Tyr Gly Glu His Lys Tyr Vali Val Gly Asp Arg Ala Met Tyr Thr Ser Phe Met Gly His Asn Thr Leu Val Leu 435 Gly Thr Asp Asp Ser Leu Gly Lys Ser 410 Ala Ala Pro Arg Ile Gin Tlir Ile Val Leu 415 'le Ala Glu Leu Ile Leu Asp 430 Lys Pro Glu Ile Leu Ser Lys Phe His His Pro Val 450 Tyr Leu Thr Lys Ala Val Pro Pro Pro Vail Val Leu Ala Lys Ala Met Leu Ile Met Arg Val Gly Leu Ala Pro Glu Asr. Asn Met Ile Leu Glo Tyr 500 505 <210> 3 <211>' 2069 (212> DNA <213> Zea mays <400> 3 tctaqatttt tt--tcaattc aaattatatg gccatattat acctatttat aacaaacatc gttctttttc tcztgtaact taagttagca ccactgtaat ttggactgtc cttttgccaa accccgagta agaagcaact zgccaagaat cttatzaata tagattttgt acaagtagaa aatatccaat aaataaaatg acaaztcttt aaacattttt ctggaacaat aatggaaccg cacaatctaa zgcgttgtat tatacacaac ggctattaaa ttctctgact ctccttaaaa aaatcaggag tgaaaaaaaa 120 t,:atatgtga 180 taatqgcaac 240 aagaagctat 300 aaccattctc 360 WO 01140440 acatcgctqg tagtatqtqt tcagtagaac tgatgtatga caaaacaaag tctctctcca aatattgcta at tttaata a cgaatgqgaa tgccttgctg ggacaaqagt agccacatgg gtgagtctga gtggtgccag tcctaggggc gaggcgggcg tccacgcgat gtgcttcctt agccagtatg cgaattggta aactgtttaa aaacccat cg tcacagaggt atgctgcggt atcgcatcta ccttcaattg tccccgacca tctctcgcgc gagaagggag PCTUS0O/32645 gtgctgaata tataaaatca tactcacgga ccgtcjaccgt ttgtattgta ttatcacagg gcatttacqt aactgtaaat acaccacaac ttccgtgaac ctttacatgc caccctgccq caccqcacca gctctcggcg caggacgaag taaccaggag caaaagcgcc caaattctgg atgagcacga gtgtctgctt acttatatat aatttatgaa agccactgcc ccagcaaaag ccgcggctag tggcaqtggc cacagcccaa ggcgctcgct ggaattaagg aaactgaaaa ttttaccaat gctaaaacaa gagctaaagt tggccraaat atgtaactgt ctacggaatt cgtctggctt aaccacgccg t tgcacgcaa aaggacaaat atcacaattc cat ggccgcc gctttggagt ctgcaccgca cttccgccac cgccacttct acctaqtgga ttgtqacgtq tttgtacacg gtagagaaat ttatgatagc gacggccgac ttcgggcctt aagctctctc cgtctcgaac caacaaggag tacctcgcct caaccatgg cattagct--t taccttttta aaaaagttgt ccaaaaaaaa tacagcacac aaaaattttg tattgaaaaa cgt--tctgga ctgcgttctg ggacgagagc aaczcccacg acaggcccag gtaggccgtg cggtgccatg caagcqggcc gcttgagacc aaaggtcagg tcaatttacg ttggqqgtca tgatagcatt tagtccaact aggtatccta ggcctcccat ccggcaatcc ttcctccctc cctctataaa cgcggcggcc cgcattccgt ttatagctct aataactgta tctactgata aaactgctcc tgacaccaca tatgttaaac atgtagtatt tggaggataa caaatcacat ctttctccct ccccccaccg gcttcccgtg cctacgcacc ccgcggggt c gcgcgtcact acgtgacggc ggtct tgcgt tacacctcag tqgtcaatg tgattcqttc catgcttaat tccattgtca ttcgctcccc gccggcgccc cgat ccggtg tcccccacc cctcct Lcct tcgagcaggg cgctctctgc cgtagtttca aaagcagaga acaataacga cgtatattat atttgtagta gttttatata atagtgaata qaccgatcaq ttgcatgcaa tgctttggca gtcgcgtgcc aaogcgactc cgtggaccgc ccgtgaccgt gca gaggagc tctgcccctc caaccgatgc caaccgagca attcaatttg aaaaagtata tcqct cacag tcctactcct gtcggctcaa gggtccattt cggacaccct tcctcccact gagcggcagt 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2069

Claims (5)

15-12-08:14:22 t 4/ 7 Claims 1. An isolated DNA molecule comprising a MIP synthase promoter, wherein said promoter comprises a sequence defined by base pairs 7-2064 of SEQ ID NO:3. 2. An isolated DNA molecule of claim 1 comprising a fragment, genetic variant or deletion of the sequence defined by base pairs 7-2064 of SEQ ID NO:3, and wherein said sequence retains the ability of functioning as a promoter in plant cells. 3. A fragment, genetic variant or deletion of the molecule of claim 2 that comprises at least 200 consecutive base pairs identical to 200 consecutive base pairs of the sequence dcfined by base pairs 7-2064 of SEQ ID NO:3. 4. An isolated DNA molecule having a 20 base pair nucleotide portion identical in sequence to a 20 consecutive base pair portion of the sequence set forth in base pairs 7- 2064 of SEQ ID NO:3. 15 5. A DNA construct comprising a promoter operably linked to a heterologous nucleic acid sequence, wherein the promoter selectively hybridizes to SEQ ID NO:3. 6. A DNA construct of claim 5 wherein the promoter comprises base pairs 7-2064 of SEQ ID NO:3. S* 7. A method of expressing a heterologous nucleic acid sequence in a plant comprising: a) introducing into a plant cell a vector comprising a MIP synthase promoter operably linked to the heterologous nucleic acid sequence; and b) regenerating a plant from said cell, wherein said MIP synthase promoter comprises a sequence defined by base pairs 7- 2064 of SEQ ID NO:3. 8. A method of producing seed comprising: a) introducing into a plant cell a vector comprising a MIP synthase promoter operably linked to a heterologous nucleic acid sequence; 23 COMS ID No: SBMI-05683165 Received by IP Australia: Time 15:31 Date 2006-12-15 15-12-05;14:22 5/ 7 b) regenerating a plant from said cell; and c) sexually transmitting said MIP synthase promoter operably linked to said heterologous nucleic acid sequence to progeny, wherein said MIP synthase promoter comprises a sequence defined by base pairs 7- 2064 of SEQ ID) NQ:3. 9. The method of producing seed of claim 8 comprising the additional step collecting the seed produced by said progeny. A transformed plant comprising at least one plant cell. that contains a DNA construct of 11. Seed or grain that contains a DNA construct of claimn .24 COMS ID No: SBMI-05683165 Received by IP Australia: Time 15:31 Date 2006-12-15 12. A plant when produced by a process according to claim 7. 13. Seed when produced by a process according to claim 8. 14. An isolated DNA molecule according to claim 1 or 4 substantially as hereinbefore described, with reference to any of the Examples. A fragment, genetic variant or deletion according to claim 3 substantially as hereinbefore described, with reference to any of the Examples.
16. A DNA construct according to claim 5 substantially as hereinbefore described, with reference to any of the Examples.
17. A method according to claims 7 or 8 substantially as hereinbefore described, with reference to any of the Examples.
18. A transformed plant according to claims 10 or 12 substantially as hereinbefore described, with reference to any of the Examples.
19. Seed or grain according to claims 11 or 13 substantially as hereinbefore described, with reference to any of the Examples. DATED: 20 January, 2004 PHLLIPS ORMONDE FITZPATRICK :Attorneys for: DOW AGROSCIENCES LLC o oo *j
AU19371/01A 1999-12-02 2000-12-01 Maize mip synthase promoter Ceased AU785368B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16861299P 1999-12-02 1999-12-02
US60/168612 1999-12-02
PCT/US2000/032645 WO2001040440A2 (en) 1999-12-02 2000-12-01 Maize mip synthase promoter

Publications (2)

Publication Number Publication Date
AU1937101A AU1937101A (en) 2001-06-12
AU785368B2 true AU785368B2 (en) 2007-02-08

Family

ID=22612210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19371/01A Ceased AU785368B2 (en) 1999-12-02 2000-12-01 Maize mip synthase promoter

Country Status (13)

Country Link
US (1) US6791013B2 (en)
EP (1) EP1234045B1 (en)
JP (2) JP2004508803A (en)
CN (1) CN1413254A (en)
AR (1) AR026693A1 (en)
AT (1) ATE482279T1 (en)
AU (1) AU785368B2 (en)
BR (1) BR0016119B1 (en)
CA (1) CA2392845C (en)
DE (1) DE60045009D1 (en)
ES (1) ES2353370T3 (en)
MX (1) MXPA02005426A (en)
WO (1) WO2001040440A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009094704A1 (en) * 2008-01-31 2009-08-06 The University Of Adelaide Seed specific expression in plants
JP5158639B2 (en) 2008-04-11 2013-03-06 独立行政法人農業生物資源研究所 Genes specifically expressed in the endosperm of plants, promoters of the genes, and use thereof
CN102134569B (en) * 2010-01-25 2012-12-26 广西大学 Maize MAPK gene promoter and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011177A1 (en) * 1998-08-20 2000-03-02 Pioneer Hi-Bred International, Inc. Seed-preferred promoters

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837848A (en) * 1990-03-16 1998-11-17 Zeneca Limited Root-specific promoter
AU732026B2 (en) * 1997-02-21 2001-04-12 Regents Of The University Of California, The Leafy cotyledon1 genes and their uses
EP0990040B1 (en) * 1997-07-22 2007-10-24 Pioneer Hi-Bred International, Inc. Genes controlling phytate metabolism in plants and uses thereof
ES2308332T3 (en) * 1999-09-01 2008-12-01 Monsanto Technology Llc PLANT REGULATING SEQUENCES FOR SELECTIVE CONTROL OF GENES EXPRESSION.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011177A1 (en) * 1998-08-20 2000-03-02 Pioneer Hi-Bred International, Inc. Seed-preferred promoters

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEAN-JOHNSON ETAL 1989 J OF BIO.CHEM. 264(2) 1274-1283 *
LOPES ETAL 1991 NUCLEIC ACIDS RESEARCH 19(7):1687-1693 *

Also Published As

Publication number Publication date
EP1234045B1 (en) 2010-09-22
CN1413254A (en) 2003-04-23
MXPA02005426A (en) 2003-01-28
BR0016119A (en) 2003-06-24
ATE482279T1 (en) 2010-10-15
ES2353370T3 (en) 2011-03-01
US20020068359A1 (en) 2002-06-06
AU1937101A (en) 2001-06-12
JP2004508803A (en) 2004-03-25
CA2392845A1 (en) 2001-06-07
WO2001040440A3 (en) 2002-02-07
AR026693A1 (en) 2003-02-26
BR0016119B1 (en) 2014-11-25
WO2001040440A2 (en) 2001-06-07
CA2392845C (en) 2011-03-15
DE60045009D1 (en) 2010-11-04
US6791013B2 (en) 2004-09-14
JP2012187117A (en) 2012-10-04
EP1234045A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
US7122658B1 (en) Seed-preferred regulatory elements and uses thereof
EP1104469B1 (en) Seed-preferred promoters
US6903205B2 (en) Seed-preferred promoters from end genes
US7321031B2 (en) Seed preferred regulatory elements
CA2293738A1 (en) Regulatory sequences for transgenic plants
US7211712B2 (en) Seed-preferred regulatory elements
US20120144524A1 (en) Soybean promoter ltp4 and flower-preferred expression thereof in transgenic plants
US20090070893A1 (en) Soybean promoters and flower-preferred expression thereof in transgenic plants
AU785368B2 (en) Maize mip synthase promoter
JP3357907B2 (en) Method for shortening inflorescence internode by introducing gene of Petunia transcription factor PetSPL2
US7081566B2 (en) Seed preferred regulatory elements
US8759612B2 (en) Soybean promoters LTP2 and flower-preferred expression thereof in transgenic plants
US20040210960A1 (en) Promoter localized in the embryo surrounding region
JP4452823B2 (en) Promoter with callus and seed embryo specific expression activity
EP1210436A2 (en) Male sterile plants
US20030018995A1 (en) Plants with a modified flower and seed development
AU2002252825B2 (en) Modification of plant and seed development and plant responses to stresses and stimuli
WO2001012799A2 (en) Regulatory sequences for pollen specific or pollen abundant gene expression in plants
KR100455620B1 (en) Method for lowering pollen fertility by using tapetal layer-specific zinc finger transcriptional factor gene

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired